21
Participants
Start Date
April 23, 2018
Primary Completion Date
August 29, 2019
Study Completion Date
August 29, 2019
Co-administration of darunavir with a cardiovascular drug
Co-administration of darunavir, an HIV agent considered prone to induce drug interactions, with a cardiovascular drug (amlodipine, atorvastatin or rosuvastatin). Note that a patient will be able to participate in the intervention group and the control group if a change in his/her anti-HIV treatment occurs (study partly parallel and partly in cross-over).
Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne
Universitätsspital Basel, Basel
Centre Hospitalier Universitaire Vaudois
OTHER